{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"74","upperLimit":"95","value":"88"},{"groupId":"OG001","lowerLimit":"77","upperLimit":"97","value":"92"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"43"},{"groupId":"OG001","value":"40"}],"units":"Participants"}],"description":"Overall survival time is defined as time from randomization to the date of death from any cause and is estimated by the Kaplan-Meier method. Patients last known to be alive are censored at the date of last contact.","dispersionType":"95% Confidence Interval","groups":[{"description":"Endometrial Cancer patients receive Intensity Modulated Radiation Therapy (IMRT)","id":"OG000","title":"Endometrial Cancer: IMRT"},{"description":"Cervical patients receive Intensity Modulated Radiation Therapy (IMRT) + Chemotherapy (cisplatin)","id":"OG001","title":"Cervical Cancer: IMRT + Chemotherapy (Cisplatin)"}],"paramType":"NUMBER","populationDescription":"Eligible patients who started study treatment","reportingStatus":"POSTED","timeFrame":"From randomization to five years","title":"Rate of Overall Survival at Five Years","type":"SECONDARY","unitOfMeasure":"percentage of participants"}